Structure-activity and cross-resistance evaluations of a series of human immunodeficiency virus type 1-specific compounds related to oxathiin carboxanilide

Antimicrobial Agents and Chemotherapy

Volumn 39, Issue 12, 1995, Pages 2718-2727

  Buckheit Jr , R W ^a   Kinjerski, T L ^a   Fliakas Boltz, V ^a   Russell, J D ^a   Stup, T L ^a   Pallansch, L A ^a   Brouwer, W G ^a   Dao, D C ^a   Harrison, W A ^a   Schultz, R J ^a   Bader, J P ^a   Yang, S S ^a  

^a Frederick Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANILIDE; CALANOLIDE A; COSTATOLIDE; NSC 602670; NSC 615985; NSC 641530; OXATHIIN DERIVATIVE; OXATHIINCARBOXAMIDE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UC 25; UC 32; UC 38; UC 84; UNCLASSIFIED DRUG; ZALCITABINE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CROSS RESISTANCE; DRUG EFFECT; DRUG MIXTURE; DRUG POTENTIATION; DRUG SCREENING; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0028838466     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.39.12.2718     Document Type: Article

References (0)